Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study

Iben F Sorgenfrei, Kathrine Norrild, Per Bo Larsen, Jakob Stensballe, Doris Ostergaard, Martine E Prins, Jørgen Viby-Mogensen

306 Citationer (Scopus)

Abstract

Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.
OriginalsprogEngelsk
TidsskriftAnesthesiology
Vol/bind104
Udgave nummer4
Sider (fra-til)667-74
Antal sider8
ISSN0003-3022
StatusUdgivet - 1 apr. 2006

Fingeraftryk

Dyk ned i forskningsemnerne om 'Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study'. Sammen danner de et unikt fingeraftryk.

Citationsformater